v3.25.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net income $ 52,123 $ 28,140
Adjustments to reconcile net income to net cash from operating activities    
Depreciation and amortization 21,643 22,910
Amortization of operating lease right-of-use assets 403 429
ARO accretion expense 477 455
Amortization of debt issuance costs 737 877
Deferred income taxes 759 1,119
Share of net earnings in equity method investee (596) (531)
Distributions from equity method investee 1,530 0
Long-term incentive compensation expense 2,152 1,377
Changes in operating assets and liabilities:    
Accounts receivable 33,029 30,869
Other current assets and other assets 28,878 (7,344)
Accounts payable and accrued liabilities 39,967 (13,421)
Current portion of deferred revenue (27,518) (6,450)
Net investments in sales-type leases 10,385 3,792
Other long-term liabilities (9,160) 2,439
Net cash provided by operating activities 154,809 64,661
Cash flows from investing activities    
Purchases of property and equipment (44,123) (12,769)
Net cash used in investing activities (44,123) (12,769)
Cash flows from financing activities    
Repurchase of Class A Common Stock 0 (8,418)
Repayments of long-term debt (11,331) (9,638)
Repayments of long-term debt - related party (2,322) (2,181)
Payment of debt issuance costs (797) 0
Principal payments under finance lease liabilities (5,309) (5,002)
Taxes withheld for long-term incentive compensation (690) 0
Dividends paid (1,450) (652)
Distributions (5,761) (2,051)
Other financing activities 12 209
Net cash provided by (used in) financing activities (27,648) (27,733)
Effect of exchange rate on cash, cash equivalents, and restricted cash 72 35
Net increase in cash, cash equivalents and restricted cash 83,110 24,194
Cash, cash equivalents and restricted cash    
Beginning of period 554,495 572,458
End of period $ 637,605 $ 596,652